Search Results

UT MD Anderson Cancer Center Collaborates on Development of Proton and Helium Ion Therapy Platform

Recently, the University of Texas MD Anderson Cancer Center (UT MD Anderson) in the United States and Israeli proton therapy equipment company P-Cure reached a strategic collaboration to jointly develop and validate a compact upright particle therapy platform. The two parties aim to enable a single system to deliver both proton and helium ion beams, so that in the future the particle type can be selected based on tumor location, disease characteristics, and treatment goals. The collaboration will start with the existing proton therapy equipment. P-Cure's compact proton system has received marketing clearance from the U.S. Food and Drug Administration (FDA); the equipment uses a synchrotron to generate proton beams and delivers dose to the target area through pencil beam scan...

2026-11-09

China's Largest Fusion Power Supply System Simulation Platform Begins Trial Operation

Recently, China's largest hardware-in-the-loop simulation platform for power supply systems in the fusion field has officially entered trial operation and passed final acceptance, with its comprehensive performance reaching the leading level among comparable international platforms. This marks that China has established a complete technology chain from algorithm research and development for fusion power supply systems, hardware-in-the-loop simulation verification, to the implementation of complete equipment sets. It is reported that the platform was developed by China Fusion Energy Co., Ltd. under CNNC, relying on a fully independent real-time simulation architecture. Under operating conditions where the number of model switches exceeds 10,000, the core solving step can reach as high as 0.8 microseconds. The performance parameters of the full-chain software and hardware all meet the preset design indicators at high standards, and core technologies are fully independently controlled. The platform's commissioning...

2026-10-28

CNNC Qintong Innovatively Builds a Digital-Intelligent Operation and Maintenance Management System for Its Isotope Base

Recently, Chinatom Qinshan Isotope Co., Ltd. (hereinafter referred to as "CNNC Qintong"), centering on the isotope production base construction project, successfully built a digital-intelligent operation and maintenance (O&M) management system with the Integrated Intelligent Production Information Management Platform (IMS) as its core. By empowering full-lifecycle equipment control and intelligent decision-making, the system effectively addresses O&M management pain points in nuclear technology application scenarios with high safety requirements and high complexity. It is understood that the system, with the Integrated Intelligent Production Information Management Platform (IMS) as its management hub, has achieved unified coding and labeling of 6,799 pieces of equipment across the entire plant and "one file per unit" full-lifecycle traceability. By deeply linking equipment ledgers with maintenance plans, repair work orders and spare parts management, CNNC Qintong has not only driven the upgrade of its maintenance model toward condition monitoring and predictive maintenance, but also achieved significant cost reduction, efficiency improvement and energy consumption optimization through HVAC variable-frequency renovation and self-developed automatic calibration platforms.

2026-10-22

Sichuan Establishes Nuclear Industry Platform, Advanced Microreactor Enters Engineering Phase

Recently, the Microreactor Industry Co-construction Conference and the unveiling ceremony of Sichuan Energy Nuclear Industry Co., Ltd. were held in Chengdu, marking that China's independently developed advanced microreactor technology has officially moved from the laboratory R&D stage into a critical period of engineering demonstration and industrialization. As an important vehicle for the central-local coordinated deployment of advanced nuclear energy, the platform will connect technology, capital, and application scenarios, and shore up shortcomings in the development of distributed nuclear energy. It is reported that Sichuan Energy Nuclear Industry Co., Ltd. was jointly initiated and established by Sichuan Energy Development Group and the Nuclear Power Institute of China (NPIC), while simultaneously introducing the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, Chengdu Future Industry Venture Capital Fund, and other multi-level capital empowerment, with initial registered capital of 1 billion yuan.

2026-10-22

South Korea Plans to Build a National Collaborative Platform for Offshore Small Modular Reactors

Recently, Professor Seo Jeong of Korea Maritime and Ocean University (KMOU) proposed at the First Offshore Small Modular Reactor Network Conference held at the Busan IT Industry Promotion Agency in Busan that the commercialization of offshore Small Modular Reactors (SMRs) cannot rely solely on reactor R&D, and that a national platform linking reactor design, shipbuilding, and offshore testing must be established. The nuclear industry and the shipbuilding industry currently operate in silos, and manufacturers, research institutions, and regulatory bodies should cooperate from an early stage. Seo Jeong stated that shipborne SMRs...

2026-09-29

Miniature "Plug-and-Play" Platform Poised to Accelerate Development of New PET Radiotracers

A research team at the Keck School of Medicine of USC is working to develop a miniature plug-and-play chip platform aimed at significantly accelerating the synthesis and preparation of novel positron emission tomography (PET) radiotracers. The project aims to lower the barriers and costs of developing molecular imaging probes, and has received a four-year, $2.6 million research grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the National Institutes of Health (NIH). The project is led by Dr. Kai Chen, PhD, professor of radiology, radiation oncology, and pharmacology and pharmaceutical sciences at USC...

2026-09-27

Miniaturized Plug-and-Play Platform R&D Accelerates, Poised to Revolutionize Novel Positron Emission Tomography Radiotracer Preparation Workflow

A research team at the Keck School of Medicine of USC is developing a miniaturized plug-and-play microfluidic platform aimed at significantly accelerating the synthesis and R&D cycle of novel positron emission tomography (PET) radiotracers. The project has received a four-year, $2.6 million dedicated research...

2026-09-24

Weilan Stellar Completes China's First Stellarator Magnet Cryogenic Comprehensive Test Platform in Three Months, First Round of Magnet Testing Launched

Weilan Stellar recently completed the construction of China's first stellarator magnet cryogenic comprehensive test platform, and the first round of magnet testing has been launched. Qiu Lilong, a review expert for the cryogenic system, stated that from independent design and system integration to domestically sourced supporting equipment, Weilan Stellar took only three and a half months to integrate vacuum, cryogenics, power supply, measurement, and protection into a comprehensive test platform. The test platform fully demonstrates the team's outstanding capabilities in scientific research, engineering, and project management. As the foundation for stable operation of a stellarator, the cryogenic system's vacuum level, sealing performance, and cooling capacity are all crucial. Unlike conventional paced R&D models, Weilan Stellar has always adhered to a pragmatic,...

2026-09-23

ZAP-X Gyroscopic Stereotactic Radiosurgery Platform Makes Its Australian Debut, Expanding Precision Non-Invasive Brain Radiotherapy

ZAP Surgical, the global leader in non-invasive robotic brain surgery, recently announced that GenesisCare will become the first cancer care provider in Australia to introduce the ZAP-X Gyroscopic Radiosurgery platform. Installation of the device is scheduled to begin this month at the GenesisCare center located at St Vincent's Hospital Sydney in New South Wales, with the first patients expected to receive treatment before the end of this year. The introduction of the ZAP-X platform will significantly enhance GenesisCare's neuro-oncology diagnostic and treatment capabilities in Sydney, providing it with dedicated stereotactic radiosurgery (SRS) services. Prior to this, patients receiving S...

2026-09-17

Nusano Selected for U.S. Nuclear Energy Launch Platform Program to Advance Advanced Nuclear Fuel Production Line

Nusano, Inc., a physics company based in West Valley City, Utah, that has made breakthroughs in radioisotope and nuclear fuel production, has been selected by the U.S. Nuclear Reactor Innovation Center (NRIC) and the U.S. Department of Energy (DOE) to participate in the development of a HALEU (high-assay low-enriched uranium) nuclear fuel production line as part of the Nuclear Energy Launch Platform program. The program is a federal government initiative aimed at accelerating innovative nuclear technologies from concept to commercial deployment. Through this program, Nusano will receive authorization process support from the U.S. Department of Energy, expertise from national laboratories, infrastructure, technical resources, and project support, thereby accelerating the development of advanced nuclear technologies...

2026-09-15

Denmark's Region East Denmark to expand Sectra One imaging platform, unifying regional nuclear medicine and other medical imaging services

Swedish medical imaging IT and cybersecurity company Sectra has recently signed a contract to expand the application of its Sectra One enterprise imaging solution from hospitals in Denmark's Capital Region to the entire Region East Denmark. Region East Denmark was formed by merging the Capital Region and Region Zealand, and this expansion aims to promote unified operation of imaging services across hospitals in the entire region. Under the contract, Sectra One will be delivered as a fully managed cloud service, covering all hospitals in Region East Denmark for the review and storage of radiology medical images, including breast imaging, nuclear medicine, and clinical physiology. Hospitals in Region Zealand will migrate to the system currently in use in the Capital Region,...

2026-09-11

Australia's First ZAP-X Gyroscopic Radiosurgery Platform to Be Installed at St Vincent's Hospital Sydney

ZAP Surgical Systems has announced that GenesisCare will become the first cancer treatment provider in Australia to introduce the ZAP-X Gyroscopic Radiosurgery® platform. The device is expected to be installed this month at GenesisCare's center at St Vincent's Hospital in Sydney, New South Wales, with the first patients anticipated to begin treatment before the end of the year. The deployment of the ZAP-X platform will enhance GenesisCare's neuro-oncology treatment capabilities in Sydney, enabling it to deliver dedicated stereotactic radiosurgery (SRS). Previously, SRS patients were primarily treated using cobalt-60 systems and multi-purpose radiotherapy linear accelerators. The ZAP-X, in contrast, is a dedicated platform designed for non-inv...

2026-09-09

Russia's EVRAZ Plans to Develop High-Performance Railway Rails Using SKIF Synchrotron Radiation Platform

Russian railway infrastructure component manufacturer EVRAZ PJSC plans to cooperate with the SKIF Collective Use Center to develop new alloys and high-performance rails using synchrotron radiation experimental capabilities, aiming to improve the mechanical properties and operational reliability of rails. At a roundtable discussion on "Development of New Structural and Tool Materials and Mechanical Engineering Technologies Using Synchrotron Radiation" held during the Technoprom 2026 forum, participating experts discussed the application prospects of the SKIF Collective Use Center in the development of high-quality rolled metal products. EVRAZ stated that Russia's railway operating environment is complex, with long line distances, numerous mountain routes, prominent low-temperature conditions, coupled with growing freight volumes, placing higher demands on steel materials...

2026-09-07

Canada's Devonian Integrates HPLC-MS, NMR, and Cell-Based Potency Assays into Thykamine Quality Control Platform

Devonian Health Group Inc., a Canadian clinical-stage biopharmaceutical company, recently announced that it has completed independent validation of key analytical methods and biological quality control technologies and integrated them into the extraction and production process of Thykamine, the company's lead active pharmaceutical botanical candidate. According to the company, its quality control program includes validated high-performance liquid chromatography-mass spectrometry (HPLC-MS) chemical fingerprinting, nuclear magnetic resonance (NMR) spectroscopy, and cell-based biological potency assays based on the U937 human cell line. The relevant cell-based assays use macrophage inflammatory protein-1β (MIP-1β) as a biomarker of Thykamine's anti-inflammatory activity...

2026-09-02

Rock Fusion AI Platform Streamlines the Entire Stellarator Design Workflow

Recently, the AI agent collaboration platform for stellarator design independently developed by Rock Fusion has achieved full coverage of the entire design workflow, encompassing key stages such as zero-dimensional parameter design, plasma configuration optimization and performance analysis, as well as coil engineering feasibility assessment. The company stated that the platform can search over a thousand initial configurations and hundreds of thousands of coil schemes, reducing the typical design iteration cycle from several weeks to several days. Rock Fusion stellarator concept image. Leveraging this platform, Rock Fusion has completed the full-machine physics design of a medium-sized superconducting stellarator with a major radius of 2 meters and a central magnetic field of 3 tesla. Design work for the company's other devices under development is also being advanced on the same platform. Stellarators rely on external three-dimensional coils to directly generate helical magnetic fields, eliminating the need to sustain magnetic confinement through plasma current. This mechanism inherently reduces the risk of major disruptions faced by tokamaks and offers the potential for long-pulse steady-state operation. In 2025, Germany's Wendelstein 7-X (W7-X) stellarator achieved significant progress in the "triple product" metric during long-duration discharges, drawing greater attention to the stellarator route.

2026-09-02